Abstract:The emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic variants that may alter viral fitness highlights the urgency of widespread next-generation sequencing (NGS) surveillance. To profile genetic variants of the entire SARS-CoV-2 genome, we developed and clinically validated a hybridization capture SARS-CoV-2 NGS assay, integrating novel methods for panel design using double-stranded DNA (dsDNA) biotin-labeled probes, and built accompanying software. This test is the first hybrid capture-based NGS assay given Food and Drug Administration (FDA) emergency use authorization for detection of the SARS-CoV-2 virus. The positive and negative percent agreement (PPA and NPA, respectively) were defined in comparison to the results for an orthogonal real-time reverse transcription polymerase chain reaction (RT-PCR) assay (PPA and NPA, 96.7 and 100%, respectively). The limit of detection was established to be 800 copies/ml with an average fold enrichment of 46,791. Furthermore, utilizing the research-use-only analysis to profile the variants, we identified 55 novel mutations, including 11 in the functionally important spike protein. Finally, we profiled the full nasopharyngeal microbiome using metagenomics and found overrepresentation of 7 taxa and evidence of macrolide resistance in SARS-CoV-2-positive patients. This hybrid capture NGS assay, coupled with optimized software, is a powerful approach to detect and comprehensively map SARS-CoV-2 genetic variants for tracking viral evolution and guiding vaccine updates. IMPORTANCE This is the first FDA emergency-use-authorized hybridization capture-based next-generation sequencing (NGS) assay to detect the SARS-CoV-2 genome. Viral metagenomics and the novel hybrid capture NGS-based assay, along with its research-use-only analysis, can provide important genetic insights into SARS-CoV-2 and other emerging pathogens and improve surveillance and early detection, potentially preventing or mitigating new outbreaks. Better understanding of the continuously evolving SARS-CoV-2 viral genome and the impact of genetic variants may provide individual risk stratification, precision therapeutic options, improved molecular diagnostics, and population-based therapeutic solutions.

Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance

Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing

Evaluating metagenomics and targeted approaches for diagnosis and surveillance of viruses

Validation of an unbiased metagenomic detection assay for RNA viruses in viral transport media and plasma

Development and Evaluation of a Panel of Filovirus Sequence Capture Probes for Pathogen Detection by Next-Generation Sequencing

Unbiased metagenomic detection of RNA viruses for rapid identification of viral pathogens in clinical samples

A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification

Metagenomic Detection of Divergent Insect- and Bat-Associated Viruses in Plasma from Two African Individuals Enrolled in Blood-Borne Surveillance

Targeted Virome Sequencing Enhances Unbiased Detection and Genome Assembly of Known and Emerging Viruses—The Example of SARS-CoV-2

Comprehensive viral enrichment enables sensitive respiratory virus genomic identification and analysis by next generation sequencing

Broad-Range Virus Detection and Discovery Using Microfluidic PCR Coupled with High-throughput Sequencing

Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery

Monitoring viral genetic variation as a tool to improve molecular diagnostics for Mumps virus.

Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing

Microseek: A Protein-Based Metagenomic Pipeline for Virus Diagnostic and Discovery

Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights

Development of a High-throughput Sequencing Platform for Detection of Viral Encephalitis Pathogens Based on Amplicon Sequencing

Capturing sequence diversity in metagenomes with comprehensive and scalable probe design

Metagenomic pathogen sequencing in resource-scarce settings: Lessons learned and the road ahead

Use of Sequence-Independent, Single-Primer-Amplification (SISPA) for rapid detection, identification, and characterization of avian RNA viruses

Comparison of the performance of two targeted metagenomic virus capture probe-based methods using reference control materials and clinical samples